These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34179075)

  • 21. Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation.
    Zhang Q; Tang W; Stancanelli E; Jung E; Syed Z; Pagadala V; Saidi L; Chen CZ; Gao P; Xu M; Pavlinov I; Li B; Huang W; Chen L; Liu J; Xie H; Zheng W; Ye Y
    Nat Commun; 2023 Sep; 14(1):5777. PubMed ID: 37723160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
    Kim SY; Jin W; Sood A; Montgomery DW; Grant OC; Fuster MM; Fu L; Dordick JS; Woods RJ; Zhang F; Linhardt RJ
    Antiviral Res; 2020 Sep; 181():104873. PubMed ID: 32653452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity.
    Martino C; Kellman BP; Sandoval DR; Clausen TM; Marotz CA; Song SJ; Wandro S; Zaramela LS; Salido Benítez RA; Zhu Q; Armingol E; Vázquez-Baeza Y; McDonald D; Sorrentino JT; Taylor B; Belda-Ferre P; Liang C; Zhang Y; Schifanella L; Klatt NR; Havulinna AS; Jousilahti P; Huang S; Haiminen N; Parida L; Kim HC; Swafford AD; Zengler K; Cheng S; Inouye M; Niiranen T; Jain M; Salomaa V; Esko JD; Lewis NE; Knight R
    bioRxiv; 2020 Aug; ():. PubMed ID: 32839779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of the SARS-CoV-2 spike protein to glycans.
    Hao W; Ma B; Li Z; Wang X; Gao X; Li Y; Qin B; Shang S; Cui S; Tan Z
    Sci Bull (Beijing); 2021 Jun; 66(12):1205-1214. PubMed ID: 33495714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
    Dakal TC
    Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.
    Prieto-Fernández E; Egia-Mendikute L; Vila-Vecilla L; Bosch A; Barreira-Manrique A; Lee SY; García-Del Río A; Antoñana-Vildosola A; Jiménez-Lasheras B; Moreno-Cugnon L; Jiménez-Barbero J; Berra E; Ereño-Orbea J; Palazon A
    Emerg Microbes Infect; 2021 Dec; 10(1):1065-1076. PubMed ID: 34013835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
    Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB
    Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus.
    Yeh H; Vo DNK; Lin ZH; Ho HPT; Hua WJ; Qiu WL; Tsai MH; Lin TY
    Phytomedicine; 2022 Aug; 103():154215. PubMed ID: 35691077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate.
    Zheng Y; Zhao J; Li J; Guo Z; Sheng J; Ye X; Jin G; Wang C; Chai W; Yan J; Liu D; Liang X
    Int J Biol Macromol; 2021 Dec; 193(Pt B):1124-1129. PubMed ID: 34743814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding.
    Vanderlinden E; Boonen A; Noppen S; Schoofs G; Imbrechts M; Geukens N; Snoeck R; Stevaert A; Naesens L; Andrei G; Schols D
    Antiviral Res; 2023 Sep; 217():105700. PubMed ID: 37562608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion.
    Ho HPT; Vo DNK; Lin TY; Hung JN; Chiu YH; Tsai MH
    Biomed Pharmacother; 2022 Nov; 155():113766. PubMed ID: 36271550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
    Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
    J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repositioning of histamine H
    Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
    Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation Mechanism for the Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.
    Chen H; Kang Y; Duan M; Hou T
    J Phys Chem Lett; 2021 Jul; 12(27):6252-6261. PubMed ID: 34196550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry.
    Suryawanshi RK; Patil CD; Koganti R; Singh SK; Ames JM; Shukla D
    Pathogens; 2021 Jun; 10(7):. PubMed ID: 34202835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs
    Zhang Q; Chen CZ; Swaroop M; Xu M; Wang L; Lee J; Wang AQ; Pradhan M; Hagen N; Chen L; Shen M; Luo Z; Xu X; Xu Y; Huang W; Zheng W; Ye Y
    bioRxiv; 2020 Sep; ():. PubMed ID: 32699847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions.
    Kwon PS; Xu S; Oh H; Kwon SJ; Rodrigues AL; Feroz M; Fraser K; He P; Zhang F; Hong JJ; Linhardt RJ; Dordick JS
    Commun Biol; 2023 Apr; 6(1):387. PubMed ID: 37031303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.